Hyperion Defi (HYPD) Non Operating Income (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Non Operating Income of $108431.0 for Q1 2026, up 123.94% year-over-year from $48418.7 in Q1 2025, and up 37749.65% quarter-over-quarter from -$288.0 in Q4 2025.
Hyperion Defi (HYPD) Non Operating Income (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Non Operating Income for 10 consecutive years, with $108431.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income rose 123.94% year-over-year to $108431.0; the TTM figure through Mar 2026 stood at $2.0 million (up 324.19% YoY), while the FY2025 annual figure was $1.4 million, up 230.22% from the prior year.
- Non Operating Income improved to $108431.0 in Q1 2026 per HYPD's latest filing, from -$288.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $2.2 million in Q3 2025 and bottomed at -$818547.0 in Q3 2023.
- Historically, Non Operating Income has averaged -$132180.8 across 5 years, with a median of -$280530.0 in 2023.
- On a YoY basis, Non Operating Income climbed as much as 998.18% in 2022 and fell as far as 463750.62% in 2022.
- Hyperion Defi's Non Operating Income stood at -$751114.0 in 2022, then jumped by 33.35% to -$500583.0 in 2023, then slipped by 0.61% to -$503650.0 in 2024, then surged by 99.94% to -$288.0 in 2025, then surged by 37749.65% to $108431.0 in 2026.
- Business Quant data shows HYPD's Non Operating Income at $108431.0 in Q1 2026, -$288.0 in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | -56,779.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -56,779.00 |
| Mar 31, 2026 | 108,431.00 |
| Dec 31, 2025 | -288.00 |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | -337,637.00 |
| Mar 31, 2025 | -452,840.00 |
| Dec 31, 2024 | -503,650.00 |
| Sep 30, 2024 | -555,926.00 |
| Jun 30, 2024 | 634,645.00 |
| Mar 31, 2024 | -655,277.00 |
| Dec 31, 2023 | -500,583.00 |
| Sep 30, 2023 | -818,547.00 |
| Jun 30, 2023 | -254,990.00 |
| Mar 31, 2023 | -280,530.00 |
| Dec 31, 2022 | -751,114.00 |
| Sep 30, 2022 | -78,768.00 |
| Jun 30, 2022 | 2,416.00 |
| Mar 31, 2022 | 194.00 |
| Dec 31, 2021 | 162.00 |
| Sep 30, 2021 | 600.00 |